Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Coronary Artery Disease: HELP
John G. F. Cleland
Based on 13 articles published since 2008
||||
Expertise Level
The expertise of John G. F. Cleland ranks in the Graphical view (beta)
Uncounted papers?
Aliases Cleland, John G   ·   Cleland, J   ·   Cleland, John G F   ·   Cleland, J G F   ·   Cleland, John
Work Locations
Details
Most likely:    Imperial College London      
2018
  • From the Université de Lorraine, INSERM Unité 1116 and Clinical Investigation Center 1433, French Clinical Research Infrastructure Network, Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Centre Hospitalier Régional et Universitaire de Nancy, Vandoeuvre lès Nancy, France (F.Z.) · the Department of Cardiology and Berlin-Brandenburg Center for Regenerative Therapies, German Center for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin Berlin, Berlin (S.D.A.) · Janssen Research and Development, Raritan (W.M.B., C.C.N.), and Bayer U.S., Research and Development, Pharmaceuticals, Thrombosis and Hematology Therapeutic Area, Whippany (T.E.S.) - both in New Jersey · Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, and the National Heart and Lung Institute, Imperial College London, London - both in the United Kingdom (J.G.F.C.) · Janssen Research and Development, Spring House, PA (M.F.) · Northwestern University, Chicago (M.G.) · National Heart Centre Singapore and Duke-National University of Singapore, Singapore (C.S.P.L.) · the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (C.S.P.L., D.J.V.) · Brigham and Women's Hospital and Harvard Medical School, Boston (M.R.M.) · the Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis (J.D.N.) · and the Department of Medicine, Cardiology Division, University of California, San Diego, San Diego (B.G.). · Pubmed 30146935
2015
  • Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Canada. · Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. · IRCCS Policlinico San Donato, Milan, Italy. · National Institute of Cardiology, Warsaw, Poland. · National Institutes of Health/National Heart, Lung, and Blood Institute, Bethesda, Maryland. · Golden Jubilee National Hospital, Glasgow, United Kingdom. · Auckland City Hospital, Auckland, New Zealand. · British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. · Westchester Medical Center and New York Medical College, Valhalla, New York. · Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Allina Health, Minneapolis, Minnesota. · National Heart Centre, Singapore, Singapore. · National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College, London, United Kingdom. Electronic address: · Pubmed 26541919
  • Inserm Centre d'Investigation Clinique CIC 1433, UMR 1116, CHU de Nancy, Institut Lorrain du Coeur et des Vaisseaux, Université de Lorraine, Nancy, France. · Department of Medicine, Cardiology Division, University of California, San Diego, La Jolla, CA, USA. · National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, England. · Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Brigham and Women's Hospital Heart and Vascular Center, and Harvard Medical School, Boston, MA, USA. · Division of Innovative Clinical Trials, Department of Cardiology, University Medical Centre Göttingen (UMG), Göttingen, Germany. · Janssen Research & Development, LLC, 920 US 202, Raritan, NJ, USA. · Pubmed 25919061
  • Laboratory for Applied Research on Cardiovascular System, Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland; Centre for Heart Diseases, Military Hospital, Wroclaw, Poland. Electronic address: · Centre for Heart Diseases, Military Hospital, Wroclaw, Poland. · Laboratory of Molecular and Cellular Immunology, Department of Tumour Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland. · Department of Internal and Occupational Diseases and Hypertension, Wroclaw Medical University, Wroclaw, Poland. · Department of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland; Department of Physiology, Wroclaw Medical University, Wroclaw, Poland. · Centre for Heart Diseases, Military Hospital, Wroclaw, Poland; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland. · Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland. · Division of Applied Cachexia Research, Department of Cardiology, Charité Medical School, Berlin, Germany. · Division of Applied Cachexia Research, Department of Cardiology, Charité Medical School, Berlin, Germany; Centre for Stroke Research Berlin, Charité Medical School, Berlin, Germany. · Division of Applied Cachexia Research, Department of Cardiology, Charité Medical School, Berlin, Germany; Department of Innovative Clinical Trials, University Medical Centre Göttingen, Göttingen, Germany. · National Heart & Lung Institute, Imperial College, London, United Kingdom. · Pubmed 25661858
Probable:    University of Glasgow      
2018
  • From the Université de Lorraine, INSERM Unité 1116 and Clinical Investigation Center 1433, French Clinical Research Infrastructure Network, Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Centre Hospitalier Régional et Universitaire de Nancy, Vandoeuvre lès Nancy, France (F.Z.) · the Department of Cardiology and Berlin-Brandenburg Center for Regenerative Therapies, German Center for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin Berlin, Berlin (S.D.A.) · Janssen Research and Development, Raritan (W.M.B., C.C.N.), and Bayer U.S., Research and Development, Pharmaceuticals, Thrombosis and Hematology Therapeutic Area, Whippany (T.E.S.) - both in New Jersey · Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, and the National Heart and Lung Institute, Imperial College London, London - both in the United Kingdom (J.G.F.C.) · Janssen Research and Development, Spring House, PA (M.F.) · Northwestern University, Chicago (M.G.) · National Heart Centre Singapore and Duke-National University of Singapore, Singapore (C.S.P.L.) · the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (C.S.P.L., D.J.V.) · Brigham and Women's Hospital and Harvard Medical School, Boston (M.R.M.) · the Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis (J.D.N.) · and the Department of Medicine, Cardiology Division, University of California, San Diego, San Diego (B.G.). · Pubmed 30146935
Probable:    University College London      
2018
  • From the Université de Lorraine, INSERM Unité 1116 and Clinical Investigation Center 1433, French Clinical Research Infrastructure Network, Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Centre Hospitalier Régional et Universitaire de Nancy, Vandoeuvre lès Nancy, France (F.Z.) · the Department of Cardiology and Berlin-Brandenburg Center for Regenerative Therapies, German Center for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin Berlin, Berlin (S.D.A.) · Janssen Research and Development, Raritan (W.M.B., C.C.N.), and Bayer U.S., Research and Development, Pharmaceuticals, Thrombosis and Hematology Therapeutic Area, Whippany (T.E.S.) - both in New Jersey · Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, and the National Heart and Lung Institute, Imperial College London, London - both in the United Kingdom (J.G.F.C.) · Janssen Research and Development, Spring House, PA (M.F.) · Northwestern University, Chicago (M.G.) · National Heart Centre Singapore and Duke-National University of Singapore, Singapore (C.S.P.L.) · the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (C.S.P.L., D.J.V.) · Brigham and Women's Hospital and Harvard Medical School, Boston (M.R.M.) · the Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis (J.D.N.) · and the Department of Medicine, Cardiology Division, University of California, San Diego, San Diego (B.G.). · Pubmed 30146935
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 13 total) written by John G. F. Cleland about Coronary Artery Disease:

  • Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease. 2018
  • Internet-based training of coronary artery patients: the Heart Cycle Trial. 2017
  • Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. 2015
  • Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial. 2015
  • Bone marrow iron depletion is common in patients with coronary artery disease. 2015
  • Medical management of stable coronary atherosclerosis. 2013
  • Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease. 2013
  • Iron status and survival in diabetic patients with coronary artery disease. 2013
  • Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy. 2013
  • Questioning the predictive role of carotid intima-media thickness. 2011
Show List of Full Article Records
Google Searches

Learn more about John G. F. Cleland using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Imperial College London
University of Glasgow
University College London
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Imperial College London
2018
  • From the Université de Lorraine, INSERM Unité 1116 and Clinical Investigation Center 1433, French Clinical Research Infrastructure Network, Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Centre Hospitalier Régional et Universitaire de Nancy, Vandoeuvre lès Nancy, France (F.Z.) · the Department of Cardiology and Berlin-Brandenburg Center for Regenerative Therapies, German Center for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin Berlin, Berlin (S.D.A.) · Janssen Research and Development, Raritan (W.M.B., C.C.N.), and Bayer U.S., Research and Development, Pharmaceuticals, Thrombosis and Hematology Therapeutic Area, Whippany (T.E.S.) - both in New Jersey · Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, and the National Heart and Lung Institute, Imperial College London, London - both in the United Kingdom (J.G.F.C.) · Janssen Research and Development, Spring House, PA (M.F.) · Northwestern University, Chicago (M.G.) · National Heart Centre Singapore and Duke-National University of Singapore, Singapore (C.S.P.L.) · the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (C.S.P.L., D.J.V.) · Brigham and Women's Hospital and Harvard Medical School, Boston (M.R.M.) · the Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis (J.D.N.) · and the Department of Medicine, Cardiology Division, University of California, San Diego, San Diego (B.G.). · Pubmed 30146935
2015
  • Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Canada. · Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. · IRCCS Policlinico San Donato, Milan, Italy. · National Institute of Cardiology, Warsaw, Poland. · National Institutes of Health/National Heart, Lung, and Blood Institute, Bethesda, Maryland. · Golden Jubilee National Hospital, Glasgow, United Kingdom. · Auckland City Hospital, Auckland, New Zealand. · British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. · Westchester Medical Center and New York Medical College, Valhalla, New York. · Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Allina Health, Minneapolis, Minnesota. · National Heart Centre, Singapore, Singapore. · National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College, London, United Kingdom. Electronic address: · Pubmed 26541919
  • Inserm Centre d'Investigation Clinique CIC 1433, UMR 1116, CHU de Nancy, Institut Lorrain du Coeur et des Vaisseaux, Université de Lorraine, Nancy, France. · Department of Medicine, Cardiology Division, University of California, San Diego, La Jolla, CA, USA. · National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, England. · Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Brigham and Women's Hospital Heart and Vascular Center, and Harvard Medical School, Boston, MA, USA. · Division of Innovative Clinical Trials, Department of Cardiology, University Medical Centre Göttingen (UMG), Göttingen, Germany. · Janssen Research & Development, LLC, 920 US 202, Raritan, NJ, USA. · Pubmed 25919061
  • Laboratory for Applied Research on Cardiovascular System, Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland; Centre for Heart Diseases, Military Hospital, Wroclaw, Poland. Electronic address: · Centre for Heart Diseases, Military Hospital, Wroclaw, Poland. · Laboratory of Molecular and Cellular Immunology, Department of Tumour Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland. · Department of Internal and Occupational Diseases and Hypertension, Wroclaw Medical University, Wroclaw, Poland. · Department of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland; Department of Physiology, Wroclaw Medical University, Wroclaw, Poland. · Centre for Heart Diseases, Military Hospital, Wroclaw, Poland; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland. · Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland. · Division of Applied Cachexia Research, Department of Cardiology, Charité Medical School, Berlin, Germany. · Division of Applied Cachexia Research, Department of Cardiology, Charité Medical School, Berlin, Germany; Centre for Stroke Research Berlin, Charité Medical School, Berlin, Germany. · Division of Applied Cachexia Research, Department of Cardiology, Charité Medical School, Berlin, Germany; Department of Innovative Clinical Trials, University Medical Centre Göttingen, Göttingen, Germany. · National Heart & Lung Institute, Imperial College, London, United Kingdom. · Pubmed 25661858
University of Glasgow
2018
  • From the Université de Lorraine, INSERM Unité 1116 and Clinical Investigation Center 1433, French Clinical Research Infrastructure Network, Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Centre Hospitalier Régional et Universitaire de Nancy, Vandoeuvre lès Nancy, France (F.Z.) · the Department of Cardiology and Berlin-Brandenburg Center for Regenerative Therapies, German Center for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin Berlin, Berlin (S.D.A.) · Janssen Research and Development, Raritan (W.M.B., C.C.N.), and Bayer U.S., Research and Development, Pharmaceuticals, Thrombosis and Hematology Therapeutic Area, Whippany (T.E.S.) - both in New Jersey · Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, and the National Heart and Lung Institute, Imperial College London, London - both in the United Kingdom (J.G.F.C.) · Janssen Research and Development, Spring House, PA (M.F.) · Northwestern University, Chicago (M.G.) · National Heart Centre Singapore and Duke-National University of Singapore, Singapore (C.S.P.L.) · the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (C.S.P.L., D.J.V.) · Brigham and Women's Hospital and Harvard Medical School, Boston (M.R.M.) · the Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis (J.D.N.) · and the Department of Medicine, Cardiology Division, University of California, San Diego, San Diego (B.G.). · Pubmed 30146935
University College London
2018
  • From the Université de Lorraine, INSERM Unité 1116 and Clinical Investigation Center 1433, French Clinical Research Infrastructure Network, Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Centre Hospitalier Régional et Universitaire de Nancy, Vandoeuvre lès Nancy, France (F.Z.) · the Department of Cardiology and Berlin-Brandenburg Center for Regenerative Therapies, German Center for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin Berlin, Berlin (S.D.A.) · Janssen Research and Development, Raritan (W.M.B., C.C.N.), and Bayer U.S., Research and Development, Pharmaceuticals, Thrombosis and Hematology Therapeutic Area, Whippany (T.E.S.) - both in New Jersey · Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, and the National Heart and Lung Institute, Imperial College London, London - both in the United Kingdom (J.G.F.C.) · Janssen Research and Development, Spring House, PA (M.F.) · Northwestern University, Chicago (M.G.) · National Heart Centre Singapore and Duke-National University of Singapore, Singapore (C.S.P.L.) · the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (C.S.P.L., D.J.V.) · Brigham and Women's Hospital and Harvard Medical School, Boston (M.R.M.) · the Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis (J.D.N.) · and the Department of Medicine, Cardiology Division, University of California, San Diego, San Diego (B.G.). · Pubmed 30146935
University of Hull
2017
  • Clinic for Cardiac and Pulmonary Rehabilitation, Rosenquelle, Kurbrunnenstraße 5, 52077, Aachen, Germany. · Department of Cardiology, Angiology, Pneumology and Intensive Care, Medicine, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands. · ITACA Institute, Polytechnic University of Valencia, Valencia, Spain. · Life Supporting Technologies, Departamento de Tecnología Fotónica y Bioingeniería, Universidad Politécnica de Madrid, Madrid, Spain. · Department of Cardiology, Angiology, Pneumology and Intensive Care, Medicine, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Centre Suisse d'Electronique et de Microtechnique SA, 2002, Neuchâtel, Switzerland. · Servicio de Cardiología, Hospital Clínico Universitario San Carlos de Madrid, Madrid, Spain. · Clinical Trial Center Aachen, Aachen, Germany. · Institute for Cardiology and Sports Medicine, German Sports University Cologne, Cologne, Germany. · Hull-York Medical School, University of Hull, Hull, UK. · Department of Cardiology, Spire Hull and East Riding Hospital, Hull, UK. · Pubmed 27730298
2011
  • Department of Cardiology, Castle Hill Hospital, University of Hull, Kingston upon Hull HU16 5JQ, UK. · Pubmed 21156659
2013
  • Academic Cardiology Unit, Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, HU16 5JQ, UK. · Pubmed 23423522
Hull York Medical School
2017
  • Clinic for Cardiac and Pulmonary Rehabilitation, Rosenquelle, Kurbrunnenstraße 5, 52077, Aachen, Germany. · Department of Cardiology, Angiology, Pneumology and Intensive Care, Medicine, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands. · ITACA Institute, Polytechnic University of Valencia, Valencia, Spain. · Life Supporting Technologies, Departamento de Tecnología Fotónica y Bioingeniería, Universidad Politécnica de Madrid, Madrid, Spain. · Department of Cardiology, Angiology, Pneumology and Intensive Care, Medicine, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Centre Suisse d'Electronique et de Microtechnique SA, 2002, Neuchâtel, Switzerland. · Servicio de Cardiología, Hospital Clínico Universitario San Carlos de Madrid, Madrid, Spain. · Clinical Trial Center Aachen, Aachen, Germany. · Institute for Cardiology and Sports Medicine, German Sports University Cologne, Cologne, Germany. · Hull-York Medical School, University of Hull, Hull, UK. · Department of Cardiology, Spire Hull and East Riding Hospital, Hull, UK. · Pubmed 27730298
2013
  • Academic Cardiology Unit, Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, HU16 5JQ, UK. · Pubmed 23423522
Miscellaneous cities in United Kingdom
2017
  • Clinic for Cardiac and Pulmonary Rehabilitation, Rosenquelle, Kurbrunnenstraße 5, 52077, Aachen, Germany. · Department of Cardiology, Angiology, Pneumology and Intensive Care, Medicine, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands. · ITACA Institute, Polytechnic University of Valencia, Valencia, Spain. · Life Supporting Technologies, Departamento de Tecnología Fotónica y Bioingeniería, Universidad Politécnica de Madrid, Madrid, Spain. · Department of Cardiology, Angiology, Pneumology and Intensive Care, Medicine, University Hospital, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. · Centre Suisse d'Electronique et de Microtechnique SA, 2002, Neuchâtel, Switzerland. · Servicio de Cardiología, Hospital Clínico Universitario San Carlos de Madrid, Madrid, Spain. · Clinical Trial Center Aachen, Aachen, Germany. · Institute for Cardiology and Sports Medicine, German Sports University Cologne, Cologne, Germany. · Hull-York Medical School, University of Hull, Hull, UK. · Department of Cardiology, Spire Hull and East Riding Hospital, Hull, UK. · Pubmed 27730298
Royal Brompton and Harefield Trust
2015
  • Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Canada. · Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. · IRCCS Policlinico San Donato, Milan, Italy. · National Institute of Cardiology, Warsaw, Poland. · National Institutes of Health/National Heart, Lung, and Blood Institute, Bethesda, Maryland. · Golden Jubilee National Hospital, Glasgow, United Kingdom. · Auckland City Hospital, Auckland, New Zealand. · British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. · Westchester Medical Center and New York Medical College, Valhalla, New York. · Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Allina Health, Minneapolis, Minnesota. · National Heart Centre, Singapore, Singapore. · National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College, London, United Kingdom. Electronic address: · Pubmed 26541919
  • Inserm Centre d'Investigation Clinique CIC 1433, UMR 1116, CHU de Nancy, Institut Lorrain du Coeur et des Vaisseaux, Université de Lorraine, Nancy, France. · Department of Medicine, Cardiology Division, University of California, San Diego, La Jolla, CA, USA. · National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, England. · Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Brigham and Women's Hospital Heart and Vascular Center, and Harvard Medical School, Boston, MA, USA. · Division of Innovative Clinical Trials, Department of Cardiology, University Medical Centre Göttingen (UMG), Göttingen, Germany. · Janssen Research & Development, LLC, 920 US 202, Raritan, NJ, USA. · Pubmed 25919061
5 Other Locations Show
Yearly article counts 011030402110
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.